The continual growth of the HbA1c market can be attributed to several factors including a rising number of people with diabetes and rising geriatric populations. Moreover, the launch of new FDA-approved HbA1c testing kits and assays will further contribute to the substantial growth of the global HbA1c market between 2020 and 2030. To obtain better insights related to the market scenario, prominent players are focusing on collaborative initiatives with other players in the market. For instance, in 2020, Avricore Health Inc. announced the signing of a Letter of Intent (LOI) with a publicly-traded healthcare technology company and drug maker. This was aimed at integrating a propriety point-of-care blood chemistry analyzer into the company’s HealthTab real-time data reporting system to add hba1c blood glucose testing to its real-time data reporting system. By interfacing this new analyzer with the HealthTab + RASTR, HealthTab will offer HbA1c blood glucose testing, in turn, expanding its capabilities for diabetes risk detection in patients. Additionally, it will facilitate healthcare teams in managing treatment programs for diabetes.
Major Key Players of the Hemoglobin A1c (HbA1c) Testing Market are:
Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd., ARKRAY, Inc., PTS Diagnostics, Tosoh Corporation, Trinity Biotech, SEBIA, and Nova Biomedical, among others.
Download PDF to Know the Impact of COVID-19 on “Hemoglobin A1c (HbA1c) Testing Market” at: https://www.marketindustryreports.com/pdf/406
Diabetes is a major health problem of the 21st century, which causes severe long-term damages to the cardiovascular & nervous systems as well as the eyes and kidneys. Nowadays, the prevalence of diabetes is rising globally in developed as well as developing countries. Diabetes is being commonly observed among geriatric populations. For instance, according to the International Diabetes Federation, in 2019, approximately 463 million adults (20-79 years) were having diabetes and the number is expected to rise to 700 million by 2045. One in five people in the age group, 65 years & above has diabetes. Therefore, its rising prevalence has led to an increasing need for the diagnosis & monitoring of the disease. Such a rising prevalence of diabetes will, in turn, drive the market growth.
The Hemoglobin A1c (HbA1c) Testing Market is segmented on the basis of Product Types, Technology, Application and region.
Major Product Types of Hemoglobin A1c (HbA1c) Testing Market covered are:
- Instruments
- Consumables
Major Technology of Hemoglobin A1c (HbA1c) Testing Market covered are:
- Ion-Exchange High-Performance Liquid Chromatography (HPLC)
- Direct Enzymatic Assay
- Boronate Affinity Chromatography
- Turbidimetric Inhibition Immunoassay
Major Applications of Hemoglobin A1c (HbA1c) Testing Market covered are:
- Hospitals & Clinics
- Home Care
- Diagnostic Laboratories
No comments:
Post a Comment